[1]
|
肖小菊, 黎励文. 《心力衰竭的通用定义和分类》解读[J]. 中国胸心血管外科临床杂志, 2021, 28(10): 1140-1144.
|
[2]
|
李世军. 老年心力衰竭流行病学和病理生理学及预后的研究进展[J]. 中华老年心脑血管病杂志, 2021, 23(3): 318-320.
|
[3]
|
Arend, M. and Hoes, A.W. (2007) Clinical Epidemiology of Heart Failure. Heart, 93, 1137-1146.
https://doi.org/10.1136/hrt.2003.025270
|
[4]
|
Maggioni, A.P., Ulf, D., Gerasimos, F., et al. (2010) EUR Observational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure, 12, 1076-1084. https://doi.org/10.1093/eurjhf/hfq154
|
[5]
|
Yancy, C.-W., Mariell, J., Biykem, B., et al. (2016) 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology, 68, 282-293.
|
[6]
|
高永, 赵翠萍. 心力衰竭治疗药物的新变革[J]. 中国心血管病研究, 2020, 18(3): 277-281.
|
[7]
|
陈社安, 顾翔. 慢性心力衰竭起搏治疗研究概况[J]. 中国心脏起搏与心电生理杂志, 2020, 34(1): 50-54.
|
[8]
|
Rodriguez, J.B.C. (2021) Beyond Left Ventricular Ejection Fraction Improvement in the Optimization of Cardiac Resynchronization Therapy. Angiology. https://doi.org/10.1177/00033197211015551
|
[9]
|
Michael, S., Nakajima, K., Zweiker, D., et al. (2021) Contemporary ICD Use in Patients with Heart Failure Cardiology and Therapy. https://doi.org/10.1007/s40119-021-00225-7
|
[10]
|
Schlosshan, D., Diane, B., Nigel, L., et al. (2009) A Mechanistic Investigation into How Long-Term Resynchronization Therapy Confers Ongoing Cardiac Functional Benefits and Improved Exercise Capacity. The American Journal of Cardiology, 103, 701-708. https://doi.org/10.1016/j.amjcard.2008.10.041
|
[11]
|
Brignole, M., Angelo, A., Gonzalo, B.E., et al. (2013) 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy: The Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in Collaboration with the European Heart Rhythm Association (EHRA). European Heart Journal, 34, 2281-329. https://doi.org/10.1093/eurheartj/eht150
|
[12]
|
Endrj, M., Vado, A., Rossetti, G., et al. (2008) Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients. Archives of Medical Research, 39, 702-708.
https://doi.org/10.1016/j.arcmed.2008.07.004
|
[13]
|
Naqvi, S.-Y., Anas, J., Katherine, V., et al. (2019) Left Ventricular Reverse Remodeling in Cardiac Resynchronization Therapy and Long-Term Outcomes. JACC: Clinical Electrophysiology, 5, 1001-1010.
https://doi.org/10.1016/j.jacep.2019.07.012
|
[14]
|
Young, J.B., et al. (2003) Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure: The Miracle ICD Trial. JAMA, 289, 2685-2694.
https://doi.org/10.1001/jama.289.20.2685
|
[15]
|
Bristow, M.R., Saxon, L.A., Boehmer, J., et al. (2004) Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure. The New England Journal of Medicine, 350, 2140-2150.
https://doi.org/10.1056/NEJMoa032423
|
[16]
|
Cleland, J.G.F., et al. (2005) The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. New England Journal of Medicine, 352, 1539-1549. https://doi.org/10.1056/NEJMoa050496
|
[17]
|
Thébault, C., Linde, C., et al. (2012) Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure: Results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study. Circulation, 126, 822-829.
https://doi.org/10.1161/CIRCULATIONAHA.112.097709
|
[18]
|
Colin, C., Kwok, C.S., Satchithananda, D.K., et al. (2015) Cardiac Resynchronisation Therapy Is Not Associated with a Reduction in Mortality or Heart Failure Hospitalisation in Patients with Non-Left Bundle Branch Block QRS Morphology: Meta-Analysis of Randomised Controlled Trials. Heart, 101, 1456-1462.
https://doi.org/10.1136/heartjnl-2014-306811
|
[19]
|
Moss, A.J., Hall, W.J., Cannom, D.S., et al. (2009) Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. The New England Journal of Medicine, 361, 1329-1338. https://doi.org/10.1056/NEJMoa0906431
|
[20]
|
Tang, A.S.L., et al. (2010) Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. New England Journal of Medicine, 363, 2385-2395. https://doi.org/10.1056/NEJMoa1009540
|
[21]
|
Ruschitzka, F., Abraham, W.T., Singh, J.P., et al. (2013) Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex. The New England Journal of Medicine, 369, 1395-1405.
https://doi.org/10.1056/NEJMoa1306687
|
[22]
|
Haghjoo, M., Bagherzadeh, A., Farahani, M.M., et al. (2008) Significance of QRS Morphology in Determining the Prevalence of Mechanical Dyssynchrony in Heart Failure Patients Eligible for Cardiac Resynchronization: Particular Focus on Patients with Right Bundle Branch Block with and without Coexistent Left-Sided Conduction Defects. Europace, 10, 566-571. https://doi.org/10.1093/europace/eun081
|
[23]
|
Yu, C.M., Fung, J.W., Chan, C.K., et al. (2004) Comparison of Efficacy of Reverse Remodeling and Clinical Improvement for Relatively Narrow and Wide QRS Complexes after Cardiac Resynchronization Therapy for Heart Failure. Journal of Cardiovascular Electrophysiology, 15, 1058-1065. https://doi.org/10.1046/j.1540-8167.2004.03648.x
|
[24]
|
Zareba, W., Klein, H., Cygankiewicz, I., et al. (2011) Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation, 123, 1061-1072. https://doi.org/10.1161/CIRCULATIONAHA.110.960898
|
[25]
|
Sipahi, I., Carrigan, T.P., Rowland, D.Y., et al. (2011) Impact of QRS Duration on Clinical Event Reduction with Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials. Archives of Internal Medicine, 171, 1454-1462. https://doi.org/10.1001/archinternmed.2011.247
|
[26]
|
Sipahi, I., Chou, J.C., Hyden, M., et al. (2012) Effect of QRS Morphology on Clinical Event Reduction with Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials. American Heart Journal, 163, 260-267.
https://doi.org/10.1016/j.ahj.2011.11.014
|
[27]
|
Epstein, A.E., DiMarco, J.P., Ellenbogen, K.A., et al. (2013) 2012 ACCF/AHA/HRS Focused Update Incorporated into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 61, e6-75.
|
[28]
|
Madhavan, M., Mulpuru, S.K., McLeod, C.J., et al. (2017) Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series. Journal of the American College of Cardiology, 69, 211-235.
https://doi.org/10.1016/j.jacc.2016.10.064
|
[29]
|
Christine, T., Kutyifa, V., McNitt, S., et al. (2013) Effect on Cardiac Function of Cardiac Resynchronization Therapy in Patients with Right Bundle Branch Block (from the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy [MADIT-CRT] Trial. The American Journal of Cardiology, 112, 525-529.
https://doi.org/10.1016/j.amjcard.2013.04.016
|
[30]
|
Keene, D., Arnold, A.D., Jastrzebski, M., et al. (2019) His Bundle Pacing, Learning Curve, Procedure Characteristics, Safety, and Feasibility: Insights from a Large International Observational Study. Journal of Cardiovascular Electrophysiology, 30, 1984-1993. https://doi.org/10.1111/jce.14064
|
[31]
|
Zhang, W., Huang, J., Qi, Y., et al. (2019) Cardiac Resynchronization Therapy by Left Bundle Branch Area Pacing in Patients with Heart Failure and Left Bundle Branch Block. Heart Rhythm, 16, 1783-1790.
https://doi.org/10.1016/j.hrthm.2019.09.006
|
[32]
|
Brouwer, T.F., Yilmaz, D., Lindeboom, R., et al. (2016) Long-Term Clinical Outcomes of Subcutaneous versus Transvenous Implantable Defibrillator Therapy. Journal of the American College of Cardiology, 68, 2047-2055.
https://doi.org/10.1016/j.jacc.2016.08.044
|
[33]
|
Hussein, A.A. and Wilkoff, B.L. (2019) Cardiac Implantable Electronic Device Therapy in Heart Failure. Circulation Research, 124, 1584-1597. https://doi.org/10.1161/CIRCRESAHA.118.313571
|